ZNF703 is an important player in head and neck cancer

Ceren Orhan1, Burak Bakır1, Nejat Dalay1

  • 1Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

Abstract

Insights

Head and neck squamous cell carcinoma (HNSCC) shows increased Zinc finger protein 703 (ZNF703) expression, linked to gene amplification. This over-expression may activate the PI3K/Akt pathway, offering new therapeutic targets for HNSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Head and neck squamous cell carcinoma (HNSCC) presents significant treatment challenges with limited survival improvements.
  • Understanding the molecular underpinnings of HNSCC is crucial for developing effective therapies.
  • Zinc finger protein 703 (ZNF703) is an oncogenic transcription factor implicated in various cancers due to chromosome 8p12 amplification.

Purpose of the Study:

  • To investigate the expression patterns of ZNF703 in HNSCC.
  • To analyze the association between ZNF703 expression, CCND1 expression, and Akt phosphorylation in HNSCC.
  • To explore the molecular mechanisms driving HNSCC development and progression.

Main Methods:

  • Prospective study involving 105 HNSCC patients.
  • Analysis of 50 HNSCC tumor and non-cancerous tissue samples using qRT-PCR and Western blotting.
  • Correlation of ZNF703 expression with clinicopathological features, copy number variation, and survival data.

Main Results:

  • ZNF703 gene expression was elevated in 22.9% of HNSCC tumor tissues compared to normal counterparts.
  • ZNF703 over-expression was found to be associated with copy number variation.
  • Preliminary findings suggest a link between ZNF703 over-expression and the activation of the PI3K/Akt signaling pathway.

Conclusions:

  • ZNF703 over-expression is linked to copy number variations in HNSCC.
  • The over-expression of ZNF703 may contribute to HNSCC pathogenesis by activating the PI3K/Akt signaling pathway.
  • Further research into ZNF703's role could reveal novel therapeutic strategies for HNSCC.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Veins of Head and Neck01:19

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
5.0K
Arteries of the Head and Neck01:26

Arteries of the Head and Neck

The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
2.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K